UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Amendment 1)
Quarterly Report Pursuant to Section 13 or 15 (d)
of the Securities Exchange Act of 1934
For Quarter Ended June 30, 1995
Commission File Number 2-96271-B
CAS MEDICAL SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
Delaware 06-1123096
(State or other jurisdiction of (I.R.S. employer
incorporation of organization) identification no.)
21 Business Park Drive, Branford, Connecticut 06405
(Address of principal executive offices)
(Zip Code)
(203) 488-6056
(Registrant's telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.
YES [X] NO [ ]
Indicate the number of shares outstanding of each of the issuer's classes
of common stock, as of the latest practicable date.
Common Stock, $.004 par value: 9,239,479 shares as of June 30, 1995.
Preferred Stock, $.001 par value: 5,000 shares as of June 30, 1995.
<PAGE>
Notes to Financial Statements (Continued)
Selling, general and administrative expenses increased to $1,213,471
in 1995 from $981,916 in 1994, an increase of 24 percent. This increase
was due primarily to market studies performed for a new product and
additional marketing sales expenses resulting from the hiring of three
additional sales support coordinators to the staff.
The provision for income taxes of $50,000 and $1,000 for the six
month periods ended June 30, 1995 and 1994, respectively, represents state
income taxes and federal alternative minimum taxes.
These factors resulted in net profit for the period ended June 30,
1995 of $438,448, as compared to net loss of $127,798 for the same period
in 1994, an increase of $566,246.
PART II
ITEM 6 EXHIBITS AND REPORTS
(A) Exhibits
11. See Notes to Financial Statements Note 2, regarding
computation of earnings per Share.
(B) Reports on Form 8-K
None
SIGNATURES
Pursuant to the requirements of the Securities Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
CAS MEDICAL SYSTEMS, INC.
Registrant
August 15,1995 Louis P. Scheps
Date Louis P. Scheps
President and Chief Executive Officer
and Chief Financial Officer
<TABLE> <S> <C>
<ARTICLE> 5
<CIK> 0000764579
<NAME> CAS MEDICAL SYSTEMS, INC.
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-1995
<PERIOD-END> JUN-30-1995
<CASH> 629,696
<SECURITIES> 0
<RECEIVABLES> 809,279
<ALLOWANCES> 0
<INVENTORY> 850,550
<CURRENT-ASSETS> 2,309,988
<PP&E> 851,514
<DEPRECIATION> 668,282
<TOTAL-ASSETS> 2,505,920
<CURRENT-LIABILITIES> 482,178
<BONDS> 0
<COMMON> 36,963
0
500,000
<OTHER-SE> (1,177,944)
<TOTAL-LIABILITY-AND-EQUITY> 2,505,920
<SALES> 3,240,890
<TOTAL-REVENUES> 3,378,989
<CGS> 1,479,711
<TOTAL-COSTS> 1,408,798
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 2,032
<INCOME-PRETAX> 488,448
<INCOME-TAX> 50,000
<INCOME-CONTINUING> 438,448
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 438,448
<EPS-PRIMARY> .04
<EPS-DILUTED> .04
</TABLE>
